mediri
Wemedoo and mediri: Unified imaging intelligence for data-driven clinical trials
Clinical trials increasingly depend on complex imaging workflows, yet imaging data often remains siloed and disconnected from core trial systems. Through our partnership with mediri, Wemedoo integrates imaging directly into the clinical data infrastructure.
About mediri
About mediri
Mediri is a medical imaging company founded in 2004 and headquartered in Heidelberg, Germany.
mediri is a specialized imaging technology and service provider for clinical trials and medical image analysis. They support sponsors, CROs, and academic partners in improving data quality, workflow efficiency, and diagnostic reliability across imaging-based studies.
Their expertise combines browser-based imaging platforms, automated quality control, central reading services, and AI-driven research, enabling high-quality imaging data throughout the entire clinical trial lifecycle.
Their research activities focus on vendor-agnostic acquisition and evaluation of magnetic resonance images for standardized imaging biomarkers.
What this partnership delivers
Imaging integrated into clinical trials
Unified imaging and clinical data for image-driven studies
By partnering with Wemedoo, we're seamlessly combining our imaging analysis expertise with oomnia's powerful data infrastructure. Together, we're creating an end-to-end, scalable solution that meets the demands of modern, image-driven clinical trials.
Strategic partnership
A strategic partnership built around unified study data
mediri provides advanced medical imaging solutions and AI-supported tools for clinical research.
Through this partnership, Wemedoo connects mediri's mTRIAL platform within oomnia, bringing imaging capabilities directly into the clinical trial environment.
This creates a unified foundation where imaging, clinical, and operational data function together within a single system.
Imaging embedded into clinical trial execution
Through the integration of mediri's mTRIAL platform, imaging workflows are supported through a structured environment for clinical trials.
This includes:
- Site management and imaging protocol
- Image data management
- Real-time reporting
- Automatic quality check of medical image data
- Real-time control of all activities in your study
- Browser-based and pseudonymized image upload
This ensures consistent, secure, and efficient handling of imaging data across studies.
Improved data consistency and operational efficiency
By connecting imaging with clinical and operational data, the partnership enables:
- Reduced manual handoffs between systems
- Improved data consistency across study components
- More efficient collaboration between sites, imaging core laboratories, and sponsors
- Lower operational complexity in imaging-heavy trials
This leads to more reliable data and smoother study execution.
Designed for imaging-intensive clinical trials
This approach is particularly relevant for studies where imaging plays a central role in endpoints and decision-making, including:
- Oncology
- Neurology
- Imaging biomarkers and AI-driven analysis
It also supports standardized imaging assessment workflows, such as Response Evaluation Criteria in Solid Tumors (RECIST 1.1) and Response Assessment in Neuro-Oncology (RANO), including independent blinded central reads.
Supporting compliant imaging workflows
oomnia enables imaging and clinical data to be managed within a compliant and controlled environment.
This includes:
- Alignment with GxP principles and ICH-GCP guidelines
- Traceable imaging and clinical data workflows
- Software validation according to IEC 62304
- Secure data hosting in Germany (ISO / IEC 27001)
- Quality management system compliant with EN ISO 13485
This ensures data remains compliant, auditable, and inspection-ready throughout the trial lifecycle.
Partner with us
Interested in becoming a Wemedoo partner?
Let's explore how a unified clinical infrastructure can support your global research strategy.
Start a partnership